1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Targeted Sequencing 1.2.3 Whole Exome Sequencing 1.2.4 Whole Genome Sequencing 1.3 Market by Application 1.3.1 Global Next Generation Sequencing (NGS) Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Academic & Government Research Institutes 1.3.3 Pharmaceutical Companies 1.3.4 Biotechnology Companies 1.3.5 Hospitals & Clinics 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Next Generation Sequencing (NGS) Market Size (2017-2028) 2.2 Next Generation Sequencing (NGS) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Next Generation Sequencing (NGS) Market Size by Region (2017-2022) 2.4 Global Next Generation Sequencing (NGS) Market Size Forecast by Region (2023-2028) 2.5 Global Top Next Generation Sequencing (NGS) Countries Ranking by Market Size 3 Next Generation Sequencing (NGS) Competitive by Company 3.1 Global Next Generation Sequencing (NGS) Revenue by Players 3.1.1 Global Next Generation Sequencing (NGS) Revenue by Players (2017-2022) 3.1.2 Global Next Generation Sequencing (NGS) Market Share by Players (2017-2022) 3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Next Generation Sequencing (NGS) Revenue 3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio 3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2021 3.5 Global Next Generation Sequencing (NGS) Key Players Head office and Area Served 3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service 3.7 Date of Enter into Next Generation Sequencing (NGS) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Next Generation Sequencing (NGS) Breakdown Data by Type 4.1 Global Next Generation Sequencing (NGS) Historic Revenue by Type (2017-2022) 4.2 Global Next Generation Sequencing (NGS) Forecasted Revenue by Type (2023-2028) 5 Global Next Generation Sequencing (NGS) Breakdown Data by Application 5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2017-2022) 5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Next Generation Sequencing (NGS) Revenue by Company (2020-2022) 6.2 North America Next Generation Sequencing (NGS) Revenue by Type (2017-2028) 6.3 North America Next Generation Sequencing (NGS) Revenue by Application (2017-2028) 6.4 North America Next Generation Sequencing (NGS) Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Next Generation Sequencing (NGS) Revenue by Company (2020-2022) 7.2 Europe Next Generation Sequencing (NGS) Revenue by Type (2017-2028) 7.3 Europe Next Generation Sequencing (NGS) Revenue by Application (2017-2028) 7.4 Europe Next Generation Sequencing (NGS) Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Next Generation Sequencing (NGS) Revenue by Company (2020-2022) 8.2 Asia Pacific Next Generation Sequencing (NGS) Revenue by Type (2017-2028) 8.3 Asia Pacific Next Generation Sequencing (NGS) Revenue by Application (2017-2028) 8.4 Asia Pacific Next Generation Sequencing (NGS) Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Next Generation Sequencing (NGS) Revenue by Company (2020-2022) 9.2 Latin America Next Generation Sequencing (NGS) Revenue by Type (2017-2028) 9.3 Latin America Next Generation Sequencing (NGS) Revenue by Application (2017-2028) 9.4 Latin America Next Generation Sequencing (NGS) Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Company (2020-2022) 10.2 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Type (2017-2028) 10.3 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Application (2017-2028) 10.4 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Illumina 11.1.1 Illumina Company Details 11.1.2 Illumina Business Overview 11.1.3 Illumina Next Generation Sequencing (NGS) Products and Services 11.1.4 Illumina Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.1.5 Illumina Next Generation Sequencing (NGS) SWOT Analysis 11.1.6 Illumina Recent Developments 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Products and Services 11.2.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.2.5 Thermo Fisher Scientific Next Generation Sequencing (NGS) SWOT Analysis 11.2.6 Thermo Fisher Scientific Recent Developments 11.3 Pacific Biosciences of California 11.3.1 Pacific Biosciences of California Company Details 11.3.2 Pacific Biosciences of California Business Overview 11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Products and Services 11.3.4 Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.3.5 Pacific Biosciences of California Next Generation Sequencing (NGS) SWOT Analysis 11.3.6 Pacific Biosciences of California Recent Developments 11.4 Beijing Genomics Institute 11.4.1 Beijing Genomics Institute Company Details 11.4.2 Beijing Genomics Institute Business Overview 11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Products and Services 11.4.4 Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.4.5 Beijing Genomics Institute Next Generation Sequencing (NGS) SWOT Analysis 11.4.6 Beijing Genomics Institute Recent Developments 11.5 Qiagen 11.5.1 Qiagen Company Details 11.5.2 Qiagen Business Overview 11.5.3 Qiagen Next Generation Sequencing (NGS) Products and Services 11.5.4 Qiagen Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.5.5 Qiagen Next Generation Sequencing (NGS) SWOT Analysis 11.5.6 Qiagen Recent Developments 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview 11.6.3 Roche Next Generation Sequencing (NGS) Products and Services 11.6.4 Roche Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.6.5 Roche Next Generation Sequencing (NGS) SWOT Analysis 11.6.6 Roche Recent Developments 11.7 Agilent Technologies 11.7.1 Agilent Technologies Company Details 11.7.2 Agilent Technologies Business Overview 11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Products and Services 11.7.4 Agilent Technologies Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.7.5 Agilent Technologies Next Generation Sequencing (NGS) SWOT Analysis 11.7.6 Agilent Technologies Recent Developments 11.8 Perkinelmer 11.8.1 Perkinelmer Company Details 11.8.2 Perkinelmer Business Overview 11.8.3 Perkinelmer Next Generation Sequencing (NGS) Products and Services 11.8.4 Perkinelmer Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.8.5 Perkinelmer Next Generation Sequencing (NGS) SWOT Analysis 11.8.6 Perkinelmer Recent Developments 11.9 Genomatix 11.9.1 Genomatix Company Details 11.9.2 Genomatix Business Overview 11.9.3 Genomatix Next Generation Sequencing (NGS) Products and Services 11.9.4 Genomatix Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.9.5 Genomatix Next Generation Sequencing (NGS) SWOT Analysis 11.9.6 Genomatix Recent Developments 11.10 PierianDx 11.10.1 PierianDx Company Details 11.10.2 PierianDx Business Overview 11.10.3 PierianDx Next Generation Sequencing (NGS) Products and Services 11.10.4 PierianDx Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.10.5 PierianDx Next Generation Sequencing (NGS) SWOT Analysis 11.10.6 PierianDx Recent Developments 11.11 Eurofins Scientific 11.11.1 Eurofins Scientific Company Details 11.11.2 Eurofins Scientific Business Overview 11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Products and Services 11.11.4 Eurofins Scientific Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.11.5 Eurofins Scientific Recent Developments 11.12 Gatc Biotech 11.12.1 Gatc Biotech Company Details 11.12.2 Gatc Biotech Business Overview 11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Products and Services 11.12.4 Gatc Biotech Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.12.5 Gatc Biotech Recent Developments 11.13 Oxford Nanopore Technologies 11.13.1 Oxford Nanopore Technologies Company Details 11.13.2 Oxford Nanopore Technologies Business Overview 11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Products and Services 11.13.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.13.5 Oxford Nanopore Technologies Recent Developments 11.14 Bio-Rad Laboratories 11.14.1 Bio-Rad Laboratories Company Details 11.14.2 Bio-Rad Laboratories Business Overview 11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Products and Services 11.14.4 Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.14.5 Bio-Rad Laboratories Recent Developments 11.15 DNASTAR 11.15.1 DNASTAR Company Details 11.15.2 DNASTAR Business Overview 11.15.3 DNASTAR Next Generation Sequencing (NGS) Products and Services 11.15.4 DNASTAR Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.15.5 DNASTAR Recent Developments 11.16 Biomatters 11.16.1 Biomatters Company Details 11.16.2 Biomatters Business Overview 11.16.3 Biomatters Next Generation Sequencing (NGS) Products and Services 11.16.4 Biomatters Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.16.5 Biomatters Recent Developments 11.17 Partek 11.17.1 Partek Company Details 11.17.2 Partek Business Overview 11.17.3 Partek Next Generation Sequencing (NGS) Products and Services 11.17.4 Partek Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.17.5 Partek Recent Developments 11.18 New England Biolabs 11.18.1 New England Biolabs Company Details 11.18.2 New England Biolabs Business Overview 11.18.3 New England Biolabs Next Generation Sequencing (NGS) Products and Services 11.18.4 New England Biolabs Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.18.5 New England Biolabs Recent Developments 11.19 Myriad Genetics 11.19.1 Myriad Genetics Company Details 11.19.2 Myriad Genetics Business Overview 11.19.3 Myriad Genetics Next Generation Sequencing (NGS) Products and Services 11.19.4 Myriad Genetics Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.19.5 Myriad Genetics Recent Developments 11.20 Macrogen 11.20.1 Macrogen Company Details 11.20.2 Macrogen Business Overview 11.20.3 Macrogen Next Generation Sequencing (NGS) Products and Services 11.20.4 Macrogen Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) 11.20.5 Macrogen Recent Developments 12 Next Generation Sequencing (NGS) Market Dynamics 12.1 Next Generation Sequencing (NGS) Market Trends 12.2 Next Generation Sequencing (NGS) Market Drivers 12.3 Next Generation Sequencing (NGS) Market Challenges 12.4 Next Generation Sequencing (NGS) Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Targeted Sequencing Table 3. Key Players of Whole Exome Sequencing Table 4. Key Players of Whole Genome Sequencing Table 5. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Next Generation Sequencing (NGS) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 7. Global Next Generation Sequencing (NGS) Revenue by Region (2017-2022) & (US$ Million) Table 8. Global Next Generation Sequencing (NGS) Revenue Market Share by Region (2017-2022) Table 9. Global Next Generation Sequencing (NGS) Revenue by Players (2017-2022) & (US$ Million) Table 10. Global Next Generation Sequencing (NGS) Market Share by Players (2017-2022) Table 11. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2021) Table 12. Ranking of Global Top Next Generation Sequencing (NGS) Companies by Revenue (US$ Million) in 2021 Table 13. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2017-2022) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Next Generation Sequencing (NGS) Product Solution and Service Table 16. Date of Key Manufacturers Enter into Next Generation Sequencing (NGS) Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Next Generation Sequencing (NGS) Market Size by Type (2017-2022) & (US$ Million) Table 19. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2022) Table 20. Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 21. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2023-2028) Table 22. Global Next Generation Sequencing (NGS) Market Size by Application (2017-2022) & (US$ Million) Table 23. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2022) Table 24. Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 25. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2023-2028) Table 26. North America Next Generation Sequencing (NGS) Revenue by Company (2020-2022) & (US$ Million) Table 27. North America Next Generation Sequencing (NGS) Revenue by Type (2017-2022) & (US$ Million) Table 28. North America Next Generation Sequencing (NGS) Revenue by Type (2023-2028) & (US$ Million) Table 29. North America Next Generation Sequencing (NGS) Revenue by Application (2017-2022) & (US$ Million) Table 30. North America Next Generation Sequencing (NGS) Revenue by Application (2023-2028) & (US$ Million) Table 31. North America Next Generation Sequencing (NGS) Revenue by Country (2017-2022) & (US$ Million) Table 32. North America Next Generation Sequencing (NGS) Revenue by Country (2023-2028) & (US$ Million) Table 33. Europe Next Generation Sequencing (NGS) Revenue by Company (2020-2022) & (US$ Million) Table 34. Europe Next Generation Sequencing (NGS) Revenue by Type (2017-2022) & (US$ Million) Table 35. Europe Next Generation Sequencing (NGS) Revenue by Type (2023-2028) & (US$ Million) Table 36. Europe Next Generation Sequencing (NGS) Revenue by Application (2017-2022) & (US$ Million) Table 37. Europe Next Generation Sequencing (NGS) Revenue by Application (2023-2028) & (US$ Million) Table 38. Europe Next Generation Sequencing (NGS) Revenue by Country (2017-2022) & (US$ Million) Table 39. Europe Next Generation Sequencing (NGS) Revenue by Country (2023-2028) & (US$ Million) Table 40. Asia Pacific Next Generation Sequencing (NGS) Revenue by Company (2020-2022) & (US$ Million) Table 41. Asia Pacific Next Generation Sequencing (NGS) Revenue by Type (2017-2022) & (US$ Million) Table 42. Asia Pacific Next Generation Sequencing (NGS) Revenue by Type (2023-2028) & (US$ Million) Table 43. Asia Pacific Next Generation Sequencing (NGS) Revenue by Application (2017-2022) & (US$ Million) Table 44. Asia Pacific Next Generation Sequencing (NGS) Revenue by Application (2023-2028) & (US$ Million) Table 45. Asia Pacific Next Generation Sequencing (NGS) Revenue by Region (2017-2022) & (US$ Million) Table 46. Asia Pacific Next Generation Sequencing (NGS) Revenue by Region (2023-2028) & (US$ Million) Table 47. Latin America Next Generation Sequencing (NGS) Revenue by Company (2020-2022) & (US$ Million) Table 48. Latin America Next Generation Sequencing (NGS) Revenue by Type (2017-2022) & (US$ Million) Table 49. Latin America Next Generation Sequencing (NGS) Revenue by Type (2023-2028) & (US$ Million) Table 50. Latin America Next Generation Sequencing (NGS) Revenue by Application (2017-2022) & (US$ Million) Table 51. Latin America Next Generation Sequencing (NGS) Revenue by Application (2023-2028) & (US$ Million) Table 52. Latin America Next Generation Sequencing (NGS) Revenue by Country (2017-2022) & (US$ Million) Table 53. Latin America Next Generation Sequencing (NGS) Revenue by Country (2023-2028) & (US$ Million) Table 54. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Company (2020-2022) & (US$ Million) Table 55. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Next Generation Sequencing (NGS) Revenue by Country (2023-2028) & (US$ Million) Table 61. Illumina Company Details Table 62. Illumina Business Overview Table 63. Illumina Next Generation Sequencing (NGS) Product and Services Table 64. Illumina Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 65. Illumina Next Generation Sequencing (NGS) SWOT Analysis Table 66. Illumina Recent Developments Table 67. Thermo Fisher Scientific Company Details Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product and Services Table 70. Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 71. Thermo Fisher Scientific Next Generation Sequencing (NGS) SWOT Analysis Table 72. Thermo Fisher Scientific Recent Developments Table 73. Pacific Biosciences of California Company Details Table 74. Pacific Biosciences of California Business Overview Table 75. Pacific Biosciences of California Next Generation Sequencing (NGS) Product and Services Table 76. Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 77. Pacific Biosciences of California Next Generation Sequencing (NGS) SWOT Analysis Table 78. Pacific Biosciences of California Recent Developments Table 79. Beijing Genomics Institute Company Details Table 80. Beijing Genomics Institute Business Overview Table 81. Beijing Genomics Institute Next Generation Sequencing (NGS) Product and Services Table 82. Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 83. Beijing Genomics Institute Next Generation Sequencing (NGS) SWOT Analysis Table 84. Beijing Genomics Institute Recent Developments Table 85. Qiagen Company Details Table 86. Qiagen Business Overview Table 87. Qiagen Next Generation Sequencing (NGS) Product and Services Table 88. Qiagen Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 89. Qiagen Next Generation Sequencing (NGS) SWOT Analysis Table 90. Qiagen Recent Developments Table 91. Roche Company Details Table 92. Roche Business Overview Table 93. Roche Next Generation Sequencing (NGS) Product and Services Table 94. Roche Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 95. Roche Next Generation Sequencing (NGS) SWOT Analysis Table 96. Roche Recent Developments Table 97. Agilent Technologies Company Details Table 98. Agilent Technologies Business Overview Table 99. Agilent Technologies Next Generation Sequencing (NGS) Product and Services Table 100. Agilent Technologies Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 101. Agilent Technologies Next Generation Sequencing (NGS) SWOT Analysis Table 102. Agilent Technologies Recent Developments Table 103. Perkinelmer Company Details Table 104. Perkinelmer Business Overview Table 105. Perkinelmer Next Generation Sequencing (NGS) Product and Services Table 106. Perkinelmer Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 107. Perkinelmer Next Generation Sequencing (NGS) SWOT Analysis Table 108. Perkinelmer Recent Developments Table 109. Genomatix Company Details Table 110. Genomatix Business Overview Table 111. Genomatix Next Generation Sequencing (NGS) Product and Services Table 112. Genomatix Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 113. Genomatix Next Generation Sequencing (NGS) SWOT Analysis Table 114. Genomatix Recent Developments Table 115. PierianDx Company Details Table 116. PierianDx Business Overview Table 117. PierianDx Next Generation Sequencing (NGS) Product and Services Table 118. PierianDx Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 119. PierianDx Next Generation Sequencing (NGS) SWOT Analysis Table 120. PierianDx Recent Developments Table 121. Eurofins Scientific Company Details Table 122. Eurofins Scientific Business Overview Table 123. Eurofins Scientific Next Generation Sequencing (NGS) Product and Services Table 124. Eurofins Scientific Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 125. Eurofins Scientific Recent Developments Table 126. Gatc Biotech Company Details Table 127. Gatc Biotech Business Overview Table 128. Gatc Biotech Next Generation Sequencing (NGS) Product and Services Table 129. Gatc Biotech Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 130. Gatc Biotech Recent Developments Table 131. Oxford Nanopore Technologies Company Details Table 132. Oxford Nanopore Technologies Business Overview Table 133. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product and Services Table 134. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 135. Oxford Nanopore Technologies Recent Developments Table 136. Bio-Rad Laboratories Company Details Table 137. Bio-Rad Laboratories Business Overview Table 138. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product and Services Table 139. Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 140. Bio-Rad Laboratories Recent Developments Table 141. DNASTAR Company Details Table 142. DNASTAR Business Overview Table 143. DNASTAR Next Generation Sequencing (NGS) Product and Services Table 144. DNASTAR Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 145. DNASTAR Recent Developments Table 146. Biomatters Company Details Table 147. Biomatters Business Overview Table 148. Biomatters Next Generation Sequencing (NGS) Product and Services Table 149. Biomatters Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 150. Biomatters Recent Developments Table 151. Partek Company Details Table 152. Partek Business Overview Table 153. Partek Next Generation Sequencing (NGS) Product and Services Table 154. Partek Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 155. Partek Recent Developments Table 156. New England Biolabs Company Details Table 157. New England Biolabs Business Overview Table 158. New England Biolabs Next Generation Sequencing (NGS) Product and Services Table 159. New England Biolabs Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 160. New England Biolabs Recent Developments Table 161. Myriad Genetics Company Details Table 162. Myriad Genetics Business Overview Table 163. Myriad Genetics Next Generation Sequencing (NGS) Product and Services Table 164. Myriad Genetics Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 165. Myriad Genetics Recent Developments Table 166. Macrogen Company Details Table 167. Macrogen Business Overview Table 168. Macrogen Next Generation Sequencing (NGS) Product and Services Table 169. Macrogen Next Generation Sequencing (NGS) Revenue in Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Table 170. Macrogen Recent Developments Table 171. Next Generation Sequencing (NGS) Market Trends Table 172. Next Generation Sequencing (NGS) Market Drivers Table 173. Next Generation Sequencing (NGS) Market Challenges Table 174. Next Generation Sequencing (NGS) Market Restraints Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Global Next Generation Sequencing (NGS) Sales Market Share by Type: 2021 VS 2028 Figure 2. Targeted Sequencing Features Figure 3. Whole Exome Sequencing Features Figure 4. Whole Genome Sequencing Features Figure 5. Global Next Generation Sequencing (NGS) Sales Market Share by Application: 2021 VS 2028 Figure 6. Academic & Government Research Institutes Case Studies Figure 7. Pharmaceutical Companies Case Studies Figure 8. Biotechnology Companies Case Studies Figure 9. Hospitals & Clinics Case Studies Figure 10. Next Generation Sequencing (NGS) Report Years Considered Figure 11. Global Next Generation Sequencing (NGS) Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Next Generation Sequencing (NGS) Market Size 2017-2028 (US$ Million) Figure 13. Global Next Generation Sequencing (NGS) Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Next Generation Sequencing (NGS) Revenue Market Share by Region in 2017 VS 2022 Figure 15. Global Top 10 Next Generation Sequencing (NGS) Countries Ranking by Market Size (US$ Million) in 2021 Figure 16. Global Next Generation Sequencing (NGS) Market Share by Players in 2021 Figure 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2021 Figure 19. North America Next Generation Sequencing (NGS) Revenue Market Share by Company in 2021 Figure 20. North America Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2028) Figure 21. North America Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2028) Figure 22. North America Next Generation Sequencing (NGS) Revenue Share by Country (2017-2028) Figure 23. U.S. Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 24. Canada Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 25. Europe Next Generation Sequencing (NGS) Revenue Market Share by Company in 2021 Figure 26. Europe Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2028) Figure 27. Europe Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2028) Figure 28. Europe Next Generation Sequencing (NGS) Revenue Share by Country (2017-2028) Figure 29. Germany Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 30. France Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 31. U.K. Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 32. Italy Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 33. Russia Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 34. Asia Pacific Next Generation Sequencing (NGS) Revenue Market Share by Company in 2021 Figure 35. Asia Pacific Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2028) Figure 36. Asia Pacific Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2028) Figure 37. Asia Pacific Next Generation Sequencing (NGS) Revenue Share by Region (2017-2028) Figure 38. China Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 39. Japan Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 40. South Korea Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 41. India Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 42. Australia Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 43. Taiwan Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 44. Indonesia Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 45. Thailand Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 46. Malaysia Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 47. Philippines Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 48. Vietnam Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 49. Latin America Next Generation Sequencing (NGS) Revenue Market Share by Company in 2021 Figure 50. Latin America Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2028) Figure 51. Latin America Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2028) Figure 52. Latin America Next Generation Sequencing (NGS) Revenue Share by Country (2017-2028) Figure 53. Mexico Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 54. Brazil Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 55. Argentina Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 56. Middle East and Africa Next Generation Sequencing (NGS) Revenue Market Share by Company in 2021 Figure 57. Middle East and Africa Next Generation Sequencing (NGS) Revenue Market Share by Type (2017-2028) Figure 58. Middle East and Africa Next Generation Sequencing (NGS) Revenue Market Share by Application (2017-2028) Figure 59. Middle East and Africa Next Generation Sequencing (NGS) Revenue Share by Country (2017-2028) Figure 60. Turkey Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 61. Saudi Arabia Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 62. UAE Next Generation Sequencing (NGS) Revenue (2017-2028) & (US$ Million) Figure 63. Illumina Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 65. Pacific Biosciences of California Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 66. Beijing Genomics Institute Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 67. Qiagen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 68. Roche Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 69. Agilent Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 70. Perkinelmer Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 71. Genomatix Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 72. PierianDx Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 73. Eurofins Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 74. Gatc Biotech Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 75. Oxford Nanopore Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 77. DNASTAR Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 78. Biomatters Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 79. Partek Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 80. New England Biolabs Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 81. Myriad Genetics Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 82. Macrogen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2017-2022) Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Targeted Sequencing Whole Exome Sequencing Whole Genome Sequencing